海外の治験の状況「1」での検索結果
1993件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 地域
- 登録日
Authorised
- ENSAYO CLÍNICO DE FASE IV / III, DOBLE CIEGO, ALEATORIZADO, PROSPECTIVO, PARA EVALUAR LA EFICACIA DE FLUVASTATINA SOBRE LOS MARCADORES INFLAMATORIOS EN LA PROGRESIÓN HEMODINÁMICA DE LA ESTENOSIS AÓRTICA DEGENERATIVA - AORTICA 1
- Aortic stenosis
- Spain
- 2006-05-26
Authorised
- ESTUDIO DE UNA DOBLE ESTRATEGIA PARA INDUCIR Y EXPANDIR EL REPERTORIO DE CÉLULAS T BASADA EN LA ADMINISTRACIÓN DE HORMONA DE CRECIMIENTO Y VACUNA EN PACIENTES CON INFECCIÓN POR EL VIH 1
- HIV-1
- Spain
- 2006-01-23
Authorised
- ESTUDIO DE LA INFLUENCIA DE ATORVASTATINA EN LA REPLICACIÓN VIRAL PLASMÁTICA CUANDO SE ADMINISTRAN PREVIAMENTE A LA INTERRUPCION DEL TRATAMIENTO ANTIRRETROVIRAL EN PACIENTES CON INFECCION POR EL VIH-1 Y SUPRESIÓN VIRAL
- Pacientes infectados por el VIH
- Spain
- 2005-12-27
Authorised
- An open, randomized study treating refractory adult-onset Still´s disease (AOSD) with interleukin-1 receptor antagonist anakinra (KineretR), compared to an established, single anti-rheumatic drug treatment. - AOSD Study 05
- Refractory adult onset Still´s disease (AOSD)
- Finland, Sweden
- 2005-11-24
Authorised
- ‘Peripheral targeting of inhaled rhDNase in stable CF patients.’
- Cystic Fibrosis MedDRA version: 9.1 Level: LLT Classification code 10011762 Term: Cystic fibrosis MedDRA version: 9.1 Level: LLT Classification code 10011763 Term: Cystic fibrosis lung
- Netherlands
- 2007-04-02
Authorised
- Do sulphponylureas preserve cortical function during hypoglycaemia in patients with type 1 diabetes and hypoglycaemia unawareness? - Do Sulphonylureas preserve cortical function during hypoglycaemia?
- We are testing the hypothesis that closing the K ATP channels using sulphonylureas (glibenclamide) during experimental insulin induced hypoglycaemia can help retain cerebral function and help enhance symptoms of hypoglycaemia in those with type 1 diabetes and hypoglycaemia unawareness. MedDRA version: 9.1 Level: LLT Classification code 10020997 Term: Hypoglycaemia unawareness MedDRA version: 9.1 Level: LLT Classification code 10012608 Term: Diabetes mellitus insulin-dependent
- United Kingdom
- 2007-03-09
Authorised
- Prévention du cancer du sein par le létrozole chez la femme ménopausée porteuse d'une mutation brca 1/2 - LIBER
- femmes porteuses d’une mutation des gènes BRCA1 ou 2 MedDRA version: 9.1 Level: LLT Classification code 10006190 Term: Breast cancer invasive NOS
- France
- 2007-02-23
Authorised
- A Phase 1, Single-Centre, Single-blind, CPO Solution Human Patch Test in Healthy Subjects
- Not Applicable (Healthy Volunteer Study)
- United Kingdom
- 2005-12-19
Authorised
- A Phase 3, Safety and Efficacy Study of Boceprevir in Previously Untreated Subjects With Chronic Hepatitis C Genotype 1
- Chronic Hepatitis C MedDRA version: 9.1 Level: LLT Classification code 10008912 Term: Chronic hepatitis C MedDRA version: 9.1 Level: PT Classification code 10019744 Term: Hepatitis C MedDRA version: 9.1 Level: SOC Classification code 10021881 Term: Infections and infestations MedDRA version: 9.1 Level: SOC Classification code 10019805 Term: Hepatobiliary disorders
- Belgium, France, Germany, Italy, Netherlands, Portugal, Spain, United Kingdom
- 2008-06-19
Authorised
- A MULTICENTER, OPEN-LABEL STUDY TO EVALUATE THE LONG-TERM SAFETY AND EFFICACY OF CD5024 1% CREAM TREATMENT FOR UP TO 52 WEEKS IN SUBJECTS WITH PAPULOPUSTULAR ROSACEA
- PATIENTS WITH PAPULOPUSTULAR ROSACEA MedDRA version: 9.1 Level: LLT Classification code 10039218 Term: Rosacea
- Bulgaria, Czech Republic, France, Germany, Hungary, Iceland
- 2008-05-19